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Clinical and microbiological evaluation 
of non-surgical periodontal therapy in 
obese and non-obese individuals with 
periodontitis: a 9-month prospective 
longitudinal study
Objective: Obesity is a chronic disease that negatively affects an 
individual’s general and oral health. The present study aimed to compare the 
clinical and microbiological effects of non-surgical periodontal therapy with the 
full mouth disinfection (FMD) protocol on obese and non-obese individuals at 
9 months post-therapy. Methodology: This clinical study was first submitted 
and approved by the Ethics Committee. Fifty-five obese patients and 39 non-
obese patients with periodontitis were evaluated. The full-mouth periodontal 
clinical parameters, clinical attachment level (CAL), probing depth (PD), 
gingival index (GI), and plaque index (PI), were monitored at baseline, 3, 6, 
and 9 months after periodontal treatment with full mouth disinfection (FMD) 
protocol. The mean count of Tannerella forsythia, Porphyromonas gingivalis, 
Treponema Denticola, and Aggregatibacter actinomycetemcomitans was 
determined by quantitative polymerase chain reaction on subgingival biofilm 
samples. Demographic data were assessed by Chi-square test. For clinical 
and microbiological parameters, two-factor repeated-measures ANOVA was 
used. Results: In both groups, periodontal therapy using the one-stage 
full-mouth disinfection protocol significantly improved CAL, PD, GI, and PI 
(p<0.05). Obese and non-obese patients equally responded to non-surgical 
periodontal therapy (p>0.05). Microbial count found no major differences 
(p>0.05) between obese and non-obese individuals who had undergone 
non-surgical periodontal therapy. Conclusions: Obesity did not affect the 
clinical and microbiological outcomes of non-surgical periodontal therapy.
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Introduction
Periodontitis is a highly prevalent chronic 
inflammatory disease characterized by the progressive 
destruction of the tooth-supporting tissues, resulting in 
tooth loss.1,2 Periodontitis represents not only a simple 
bacterial infection, but also a complex interaction 
among host inflammatory responses, subgingival 
biofilm, and host modifying factors.3 
Among host modifying factors, several systemic 
diseases have been associated with periodontitis, 
including obesity.4,5 Obesity is a chronic disease that 
affects the individual’s general and oral health.6,7 
The cellular and molecular mechanisms that might 
explain obesity and periodontitis relationship are 
systemic inflammatory changes in tumor necrosis 
factor (TNF)-α, Interleukin-6 (IL-6), oxidative stress, 
and adiponectin and leptin levels, which may result in 
greater susceptibility to chronic inflammatory diseases 
and infections.8-10
Several epidemiological studies have established 
the relationship between obesity and periodontal 
disease.11-13 Cross-sectional studies have demonstrated 
that obese individuals present greater odds-ratio 
for periodontitis than non-obese.11,13 Moreover, 
longitudinal studies demonstrated that obesity is 
associated with increased periodontal attachment 
loss and inflammation,12,14,15 and systematic reviews 
showed that periodontitis severity and extension are 
associated with increased levels of overweight.16-18 
Previous reports showed that obese individuals 
present impaired wound healing and more infectious 
complications.19,20 Therefore, the question of whether 
these individuals would have a worse response to 
periodontal therapy than non-obese individuals was 
posed, and a few clinical studies were conducted.20-25 
Nonetheless, a systematic review evaluating obesity 
on periodontal therapy showed that the low quality of 
evidence is mainly due to the lack of studies, short-
term follow-ups, and inconsistent data, indicating the 
need for further studies.26,27
As inflammatory changes in obese individuals may 
impair wound healing and worsen periodontal status, 
this study hypothesized that obese individuals would 
present a worse response to periodontal therapy than 
non-obese ones. Although there are other studies on 
this topic, this is the first to verify the effectiveness 
of the chemical-mechanical therapy with the FMD 
protocol in obese individuals.
Thus, the aim of this prospective 9-month clinical 
study was to compare the clinical and microbiological 
effects of non-surgical periodontal therapy with the 
FMD protocol on obese and non-obese individuals.
Methodology
This 9-month, parallel group, single-center, 
clinical study was registered at Clinicaltrials.gov 
(NCT03103204) and approved by the Ethics Committee 
(protocol No. 36828114.4.0000.5501). Participants 
provided prior written informed consent for enrolling 
in this clinical study, composed of baseline, 3, 6 and 
9 month post-therapy follow ups. 
Participants
The study population was composed of participants 
with periodontitis referred to the Dental Specialties 
Center of Joinville-SC, in 2017. A total of 94 individuals 
of both genders, 45 years old or older, and presenting 
at least 12 natural teeth, body mass index (BMI) > 
18.5 kg/m2 and periodontitis were recruited. This 
prospective study included participants with moderate, 
severe, and advanced periodontitis (stage II: 
established periodontitis with characteristic damages 
caused to tooth support, including interdental CAL from 
3 to 4 mm, maximum PPD ≤ 5 mm, and radiographic 
bone loss at coronal third between 15% to 33%; stage 
III and IV: – at least interdental CAL ≥ 5mm, PPD ≥ 6 
mm  and radiographic bone loss extending to mild-third 
of the root), as described by Tonneti, et al.28 (2018). 
Sample size was calculated from the primary 
outcome data of previous studies, based on the 
clinical attachment level (CAL) gain and probing depth 
(PD) reduction.29,30 Microbial count reduction and 
the association between clinical and microbiological 
reductions were chosen as secondary outcome, based 
on the posteriori mean microbial counts observed in 
this study. Assuming a 5% α, a 90% power, and a 15% 
minimum PD reduction difference between groups, 
a total of 28 individuals within each group would be 
necessary. Notably, in this study the coefficient of 
variation for microbial count was ~15%, indicating the 
study outcome precision.29 Considering a dropout of 
up to ~20%, a total of 34 participants in each group 
were initially regarded as appropriate. 
Exclusion criteria were orthodontic devices, 
pregnancy or breast-feeding, systemic diseases or 
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other conditions that could influence the periodontal 
status (other than diabetes), alcohol abuse, medical 
condition requiring prophylactic antibiotic coverage, 
use of systemic antibiotics and/or anti-inflammatory 
drugs six months prior to the study, and history of 
periodontal therapy within six months prior to the 
study. 
Anthropometric measurements
Anthropometric measurements (weight, height, 
and waist circumference) were recorded at both 
baseline and 9 months. BMI was calculated as an 
indicator of total adiposity regarding obesity, by 
dividing bodyweight (kilograms) by the square of body 
height (meters). Obesity was defined as BMI ≥ 30 kg/
m2.31 Alongside BMI, the following waist circumference 
reference-values were considered as indicators of 
obesity: > 102 cm for men and > 88 cm for women.31 
Individuals selected were divided into two groups, 
according to their body mass index (BMI) and waist 
circumference.
Non-obese group (n= 39), BMI ≤ 29.9 kg/m2 and 
waist circumference < 102 cm for men and < 88 cm 
for women.
Obese group (n=55), BMI ≥ 30 kg/m2 and waist 
circumference > 102 cm for men and > 88 cm for 
women.
Clinical procedures
Full mouth periodontal clinical parameters were 
obtained by a single previously trained examiner 
(F.S.P.), and subsequently calibrated by a gold-
standard examiner (J.R.C.). The training and 
calibration processes followed the method described 
by Araujo, et al.32 (2003) and were performed both 
prior to the study and before the final exam. An intra-
examiner 0.85 correlation coefficient (Kappa test) for 
probing pocket depth measurements showed high 
examiner reliability. 
Periodontal clinical parameters were obtained prior 
to therapy (baseline) and at intervals of 3, 6, and 9 
months post-therapy. CAL, PD, plaque Index33 (PI), 
and gingival index34 (GI) were obtained with a manual 
periodontal probe (Hu-friedy – Chicago, IL, USA) of all 
teeth from six periodontal sites. 
Initially, participants underwent oral hygiene 
instructions. Then, as described by Quirynen, et 
al.35 (1995), the one-stage full-mouth disinfection 
protocol for periodontal therapy was performed by 
an experienced and trained periodontist (F.S.P). 
The protocol consisted of full-mouth periodontal 
debridement within 24 hours, in two sessions of one 
hour each, tongue brushing with 1% chlorhexidine 
gel for 1 minute, subgingival irrigation with 1% 
chlorhexidine gel after scaling, and mouthwashes with 
0.12% chlorhexidine for 30 seconds at the beginning 
and at the end of each session, with gargling in the 
final 10 seconds. In addition, during fourteen days, 
twice-daily, 0.12% chlorhexidine was used. Every 
three months, patients underwent oral hygiene 
instructions, dental prophylaxis and supragingival 
dental scaling.
Microbiological monitoring
As described in our previous study, subgingival 
plaque samples were collected.36 Supragingival 
dental plaque was removed using a sterile curette, 
and a sterile paper point (fine, Johnson and Johnson, 
New Brunswick, NJ, USA) was inserted into the 
gingival sulcus/periodontal pocket and kept there 
for 10 seconds. Then, paper point was placed in a 
vial containing 1.0 ml of phosphate-buffered saline 
(pH7.4), inserted in a minitube and kept on ice. 
To obtain bacterial dispersion, a vortex mixer at 
maximum speed was used for 1 min and stored in a 
freezer at -80°C until further analyses.
Following the manufacturer’s specifications, the 
genomic DNA (gDNA) was extracted and purified using 
a commercial Genomic DNA Mini Kit (Life Technologies, 
Carlsbad, CA, USA).
The total microbial count of Tannerella forsythia, 
Porphyromonas gingivalis, Treponema denticola, 
and Aggregatibacter actinomycetemcomitans was 
performed by quantitative real-time polymerase 
chain reaction (qPCR) using a  set of TaqMan (Life 
Technology, Carlsbad, CA, USA ) primers/probes in 
Real-Time PCR System, following manufacturer’s 
instructions. The qPCR conditions were: 50oC for 2 
min, 95oC for 10 min, 40 cycles of 95oC for 15 s, and 
60oC for 1 min. Figure 1 lists the primers and probes 
used in the study.
Statistical analysis
Statistical analysis was performed by the GraphPad 
Prism statistical program (GraphPad Software, La 
Jolla, CA, USA). First, data were submitted to the 
Kolmorogov-Smirnov normality test. Demographic 
data were accessed by chi-square test to verify the 
group homogeneity. Patient served as unit to evaluate 
clinical parameters. Intra and inter-group comparisons 
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were assessed by the two-factor repeated-measures 
ANOVA. Microbial counts were log-transformed, and a 
Q-Q plot of residual values showed acceptable levels 
of normality. All analyses were performed with 5% α. 
Results 
For this study, one hundred and four individuals 
were selected and divided into two groups (obese and 
non-obese). As ten subjects from the obese group 
did not attend the baseline appointment, only 94 
participants were evaluated. Five individuals of the 
obese group and two of the non-obese were lost during 
follow-up visits. Figure 2 shows the flow diagram of 
the study design.
Table 1 shows participants’ sociodemographic 
and behavioral characteristics, and health conditions 
for both groups. There was no significant difference 
between the groups regarding age, sex, ethnicity, 
diabetes, and smoking habits. Obese individuals 
showed increased BMI and waist circumference. 
Moreover, the obese groups had a greater prevalence 
of participants with arterial hypertension (P=0.001).
All subjects reported no side effect caused by the 
treatment.
Clinical outcomes
Table 2 shows periodontal clinical parameters 
observed in both groups at baseline, 3, 6, and 
9 months post-treatment. Periodontal chemical-
mechanical therapy using the one-stage full-mouth 
disinfection protocol significantly improved all clinical 
parameters (PD, CAL, GI, and PI) for both groups 
(p<0.05). However, the two of them equally responded 
to non-surgical periodontal therapy with no statistically 
significant differences in CAL, PD, GI, and PI after 9 
months.
Microbiological results
Table 3 shows microbial count at baseline, 
3, 6, and 9 months. Total bacterial load was not 
significantly different among follow-up periods and 
groups (p<0.05).  Within 9 months, P. gingivalis and 
A. actinomycetemcomitans significantly decreased in 
both groups (p<0.05) with no significant difference 
between groups.  At 6 months, T. forsythia decresead 
significantly in the non-obese group, whereas for 
the obese group small counts were observed only 
at 3 months. These reductions, however, were not 
maintained in both groups at 9 months. Although 
no difference between groups was observed at any 
period, periodontal treatment reduced T. denticola 
count within the obese group (p<0.05).
Discussion
The objective of this 9-month clinical study was 
to determine whether obese individuals present a 
worse response to periodontal therapy than non-obese 
ones. Although few studies have been performed on 
Microrganism Primers
P. gingivalis For: ACCTTACCCGGGATTGAAATG
Rev: CAACCATGCAGCACCTACATAGAA
Probe: TGACTGATGGTGAAAACCGTCTTCCCTTC
T. forsythia For: AGCGATGGTAGCAATACCTGTC
Rev: TTCGCCGGGTTATCCCTC
Probe: CACGGGTGAGTAACG
T. denticola For: CCGAATGTGCTCATTTACATAAAGGT
Rev: GATACCCATCGTTGCCTTGGT
Probe: ATGGGCCCGCGTCCCATTAGC






Figure 1- Specific primers and probes used in the study
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this matter, this study was conducted because (1) 
the literature presents controversial data,26 (2) most 
studies have 2-6 months follow-ups,22-25 (3) studies 
combining mechanical and chemical procedures are 
lacking and (4) systematic reviews indicate the need 
for further studies.26,27 
The main findings presented here indicate 
that obesity (BMI > 30 kg/m2) does not affect the 
clinical and microbiological outcomes of non-surgical 
periodontal therapy. As obesity has recently become 
pandemic,37 groups were divided into non-obese and 
obese individuals to achieve a greater reproducibility 
and reliability for the overall population. Besides, a 
stratified preliminary analysis showed no significant 
difference between overweight and normal-weight for 
all parameters. Thus, as the aim was to assess whether 
obese people had a worse response to periodontal 
therapy than non-obese, overweight was included in 
Figure 2- Flow chart of the study design
Variables Non-Obese (n=39) Obese (n=55) p-Value
Mean age in years (SD) 50.7(7.1) 48.9(7.8) 0.94
Gender: Male (%) 14(35.9) 19(34.5) 0.89
Ethnicity: Non-Caucasian (%) 3(7.7) 7(12.7) 0.51
BMI (mean SE) 25.8(0.5) 36.12(0.57) 0.001*
Waist circumference (mean SE) 90.34(1.86) 110.89(1.4) 0.001*
n (%) diabetes 2(5.1) 9(16.4) 0.11
n (%) of arterial hypertension 3(7.7) 30(54.5) 0.001*
Number (%) of smokers 5(12.8) 4(7.3) 0.48
*: Indicate significant differences between groups  (p < 0.05).   
n: number; SE: standard error; SD: standard deviation
Table 1- Sociodemographic, behavioral and health condition characteristics of Obese and non-Obese groups
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the non-obese group. Although one may speculate that 
BMI is a general indicator of body size and not obesity, 
demographic data demonstrated significant differences 
in waist circumference between groups, considered a 
reliable indicator of intra-abdominal adipose tissue and 
increased risk of cardiometabolic disease.38





PD(mm) Baseline 2.98 ± 0.5 2.90 ± 0.3 0.553
3 months 2.34 ± 0.4* 2.26 ± 0.3* 0.413
6 months 2.22 ± 0.5* 2.24 ± 0.4* 0.87
9 months 2.27 ± 0.5* 2.22 ± 0.4* 0.97
CAL(mm) Baseline 4.23 ± 1.2 4.03 ± 0.9 0.525
3 months 3.66 ± 1.2* 3.61 ± 1.0* 0.814
6 months 3.64 ± 1.1* 3.50 ± 1.0* 0.549
9 months 3.67 ± 1.1* 3.53 ± 1.0* 0.705
PI Baseline  0.54 ± 0.32  0.51 ± 0.36 0.624
3 months  0.45 ± 0.31*  0.39 ± 0.22* 0.25
6 months  0.33 ± 0.23*  0.37 ± 0.21* 0.282
9 months  0.32 ± 0.20*  0.32 ± 0.22* 0.813
GI Baseline 0.32 ± 0.32 0.37 ± 0.25 0.431
3 months 0.29 ± 0.19 0.28 ± 0.14* 0.662
6 months 0.25 ± 0.20* 0.24 ± 0.26* 0.806
9 months 0.27 ± 0.15* 0.23 ± 0.22* 0.218
*: indicate significant differences when compared with baseline by repeated measures ANOVA and Tukey’s tests (p < 0.05).
PD, probing depth; CAL, clinical attachment level; PI: plaque index; GI: gingival index; n: number; SD: standard deviation.
Table 2- Means (±SD) of full-mouth clinical parameters for both groups at baseline and follow-up visits






P. gingivalis Baseline 21.03(8.77) 17.06(4.62) 0.653
3 months 17.07(10.53) 3.65(1.22)*  0.030#
6 months 5.10(2.15)* 9.81(2.81)* 0.185
9 months 10.58(4.79)* 13.88(5.49)* 0.72
T. forsythia Baseline 50.38(21.51) 58.52(18.77) 0.785
3 months 33.31(11.85) 22.05(7.20)* 0.376
6 months 21.36(6.89)* 55.87(16.24) 0.025#
9 months 45.70(21.50) 33.24(8.79) 0.533
T. denticola Baseline 11.66(4.55) 18.14(6.01) 0.393
3 months 6.52(2.22) 5.64(1.51)* 0.715
6 months 9.60(2.80) 14.77(4.09) 0.279
9 months 9.99(2.53) 7.14(2.32)* 0.482
A.   actinomycetemcomitans Baseline 73.36(11.75) 92.04(20.66) 0.227
3 months 71.57(22.95) 65.55(36.59) 0.877
6 months 46.85(18.09)* 48.22(15.36)* 0.954
9 months 22.28(9.99)* 21.05(6.55)* 0.873
Total load Baseline 11.85(2.41) 12.60(2.41) 0.818
3 months 10.24(1.79) 7.75(1.33) 0.235
6 months 9.12(1.70) 11.22(1.75) 0.39
9 months 8.52(1.44) 9.10(1.61) 0.902
*: indicate significant differences over time by repeated measures ANOVA and Tukey’s tests (p < 0.05).
# : Indicate differences between treatment groups at each time point by repeated measures ANOVA and Tukey’s tests (p < 0.05).
n: number; SE: standard error
Table 3- Mean number of periodontal pathogens (SE) for both groups at baseline and at follow-up visits
Clinical and microbiological evaluation of non-surgical periodontal therapy in obese and non-obese individuals with periodontitis: a 9-month prospective longitudinal study
J Appl Oral Sci. 2020;28:e201906947/9
Periodontal therapy using the one-stage full-mouth 
disinfection protocol effectively reduced periodontal 
inflammation, improving all clinical parameters (PD, 
CAL, and GI). Yet, obese and non-obese individuals 
showed no significant difference during the study 
follow-up period. These results might be explained 
by the disease low severity at baseline, as well 
as  the presence of more smokers within the non-
obese group, although not statistically different,. 
Nevertheless, these findings corroborate other clinical 
studies21,22,39 and two systematic reviews,26,27 which 
found that obese and non-obese subjects have a 
similar periodontal response to nonsurgical mechanical 
periodontal therapy. Conversely, other studies 
observed an impaired response to periodontal therapy 
in obese individuals.23-25 These divergent results could 
be explained by: different follow-up periods, as some 
studies present 2 months,23 3 months21,39 and 6 months 
follow-ups,24,25 wheread this study had a 9-month 
follow-up;  differences in sample size and treatment 
protocol; as well as the inclusion of patients solely 
with severe periodontitis.25
Although clinical studies have shown the efficacy 
of the one-stage full-mouth disinfection in patients 
with periodontitis,40 this is the first to demonstrate 
it in obese individuals. The one-stage full-mouth 
disinfection protocol was chosen for this study 
for the following reasons: a shorter number of 
clinical sessions, a shorter treatment time, greater 
compliance, and cost-effectiveness.35
P. gingivalis, T. forsythia, and T.denticola, usually 
called “red complex”, and A. actinomycetemcomitans 
are considered the main pathogens associated 
with periodontal disease.41 Some speculate that 
obese individuals with periodontitis present higher 
proportions of subgingival periodontal pathogens 
than normal-weight individuals, increasing the risk 
for progressive attachment loss and periodontitis 
development.42 In this study, obesity did not impact 
the changes on overall bacterial load during follow-up. 
Furthermore, both treatments significantly reduced 
P. gingivalis and A. actinomycetemcomitans at 9 
months, and T. denticola count was only reduced 
within the obese group. This can be explained by the 
differences in T. denticola count at baseline. As the 
obese group showed a greater T. denticola count, it 
is reasonable that the periodontal treatment led to 
a greater reduction within this group. Periodontal 
therapy did not affect T. forsythia count in the obese 
and non-obese groups. Therefore, there were no major 
differences in microbial count when comparing obese 
and non-obese individuals undergoing one-stage 
full-mouth disinfection. These findings corroborate a 
recent 3-month prospective clinical study, which found 
no significant differences in P. gingivalis, T. forsythia, 
and P. intermedia mean counts between obese and 
normal-weight individuals on periodontal therapy.43
Diabetes is a risk factor for periodontitis.44 In this 
study, two individuals (5.1%) of the non-obese group 
and nine (16.4%) in the obese group had diabetes. 
Nonetheless, there was no significant difference 
between groups, what indicates homogeneity. 
Moreover, although speculated that patients with 
diabetes may have a worse periodontal response 
than non-diabetic, a recent systematic review showed 
that diabetes mellitus does not significantly impact 
periodontal clinical parameters of non-surgical 
periodontal therapy.45 In addition, to increase this 
study external validity, smokers were included. There 
was no significant difference between groups regarding 
the number of smokers, but periodontal therapy is 
proved to be less effective within this population,46 
which may serve as a possible source of bias. The 
inclusion of overweight individuals into the control 
group may have presented a potential bias and a 
limitation for this study. Furthermore, prospective 
studies should assess how changes in anthropometric 
measurements during follow-up may impact results.
Considering the increase of obese individuals, 
this study results could widely contribute to dental 
practices. The one-stage full-mouth disinfection 
seemed a reliable protocol to treat periodontitis in 
obese individuals.
Conclusion
Obesity did not affect the clinical and microbiological 
outcomes of non-surgical periodontal therapy. 
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